J Parathyr Dis. 2021;
9: e11153.
Abstract View: 318
PDF Download: 125
Letter to Editor
Baricitinib in COVID-19; a letter to editor on recent findings
Mehrdad Rabiee Rad
1 
, Ghazal Ghasempour Dabaghi
1* , Hedayat Vali Rahvard
2 , Hamid Reza Jahantigh
3 1 School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
2 Physiotherapy Bachelor Course, Department of Physiotherapy, Babol University of Medical Science, Babol, Iran.
3 Interdisciplinary Department of Medicine - Section of Occupational Medicine, University of Bari, Bari, Italy.
Please cite this paper as: Rabiee Rad M, Ghasempour Dabaghi G, Vali Rahvard H, Jahantigh HR. Baricitinib in COVID-19; a letter to editor on recent findings. J Parathyr Dis. 2021;9:e11153.
Abstract View: 319
| years | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| 2024 | 11 | 13 | 17 | 8 | | | | | | | | |
| 2023 | 16 | 25 | 22 | 10 | | 11 | 18 | 13 | 22 | 29 | 32 | 10 |
| 2022 | | | | | | | | | | 12 | 25 | 25 |
PDF Download: 125
| years | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| 2024 | 8 | 8 | 10 | 6 | | | | | | | | |
| 2023 | 7 | 3 | 3 | 2 | 2 | 12 | 11 | 11 | 11 | 11 | 4 | 5 |
| 2022 | | | | | | | | | | 4 | 1 | 6 |